MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$481K
Free Cash flow
-$6,987K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Common stock purchased and retir...
Payment of dividends
Deferred income taxes
Others
Negative Cash Flow Breakdown
Net income
Inventories
Amortization
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2025-09-30
2025-06-30
Net income
-3,430
2,631
6,089
Depreciation
-193
209
405
Amortization
-1,115
545
1,048
Provision for (recovery of) losses on accounts receivable
-407
402
-7
Amortization of right-of-use assets
-11
15
26
Deferred income taxes
463
-281
-360
Stock-based compensation expense
-70
94
168
Tax benefit attributable to exercise of stock options
0
0
0
Accounts receivable and other receivables
-41
506
-409
Inventories
2,139
-101
-908
Prepaid expenses and other current assets
74
93
-145
Accounts payable
-103
32
37
Accrued expenses
315
729
-1,531
Total adjustments
-3,293
1,247
1,248
Net cash provided by operating activities
-6,723
3,878
7,337
Intangible assets
-
0
0
Property and equipment
264
0
0
Net cash used in investing activities
-2
-27
-235
Proceeds from issuance of common stock - options
-
0
0
Common stock purchased and retired
-7,155
653
6,708
Payment of dividends
-1,030
988
2,018
Net cash used in financing activities
8,185
-1,641
-8,726
Effect of exchange rate changes on cash
-979
-122
827
Net increase/(decrease) in cash and cash equivalents
481
2,088
-797
Cash at beginning of period
84,267
82,976
-
Cash at end of period
87,528
84,267
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Common stock purchased
and retired
-$7,155K
(-206.66%↓ Y/Y)
Payment of dividends
-$1,030K
(-151.04%↓ Y/Y)
Net cash used in
financing activities
$8,185K
(193.80%↑ Y/Y)
Net
increase/(decrease) in cash and cash...
$481K
(160.35%↑ Y/Y)
Canceled cashflow
$7,704K
something is missing
$262K
Net cash provided by
operating activities
-$6,723K
(-191.63%↓ Y/Y)
Effect of exchange rate
changes on cash
-$979K
(-218.38%↓ Y/Y)
Net cash used in
investing activities
-$2K
(99.15%↑ Y/Y)
Canceled cashflow
$262K
Deferred income taxes
$463K
(228.61%↑ Y/Y)
Accrued expenses
$315K
(120.57%↑ Y/Y)
Accounts receivable and
other receivables
-$41K
(89.98%↑ Y/Y)
Net income
-$3,430K
(-156.33%↓ Y/Y)
Total adjustments
-$3,293K
(-363.86%↓ Y/Y)
Property and equipment
$264K
Canceled cashflow
$819K
Inventories
$2,139K
(335.57%↑ Y/Y)
Amortization
-$1,115K
(-206.39%↓ Y/Y)
Provision for (recovery
of) losses on...
-$407K
(-5714.29%↓ Y/Y)
Depreciation
-$193K
(-147.65%↓ Y/Y)
Accounts payable
-$103K
(-378.38%↓ Y/Y)
Prepaid expenses and
other current assets
$74K
(151.03%↑ Y/Y)
Stock-based compensation
expense
-$70K
(-141.67%↓ Y/Y)
Amortization of right-of-use
assets
-$11K
(-142.31%↓ Y/Y)
Buy us a coffee
UTAH MEDICAL PRODUCTS INC (UTMD)
UTAH MEDICAL PRODUCTS INC (UTMD)